Insiders · Profile

Malabre Richard C

SVP, Chief Accounting Officer at Akebia Therapeutics. Filing since 3 Feb 2025. CIK 0002007730

Company
Date
Role
Action
Shares
Amount
Of holding
2 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
49,524
$68.84K
14.2%
9 Jun 2025
SVP, Chief Accounting Officer
Sold on a plan
15,000
$60.15K
5.3%
4 Jun 2025
SVP, Chief Accounting Officer
Sold on a plan
13,334
$47.07K
4.8%
3 Feb 2025
SVP, Chief Accounting Officer
Sold on a plan
30,202
$63.42K
9.7%
4 decisions on file.